GERN – Geron Corporation
GERN
$1.43Name : Geron Corporation
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $907,608,128.00
EPSttm : -0.21
Geron Corporation
$1.43
Float Short %
10.81
Margin Of Safety %
Put/Call OI Ratio
0.15
EPS Next Q Diff
EPS Last/This Y
0.15
EPS This/Next Y
0.06
Price
1.48
Target Price
3.69
Analyst Recom
1.78
Performance Q
-9.7
Relative Volume
1.36
Beta
0.67
Ticker: GERN
19 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-06-02 | GERN | 1.44 | 0.13 | 0.05 | 105504 |
2025-06-03 | GERN | 1.575 | 0.13 | 0.00 | 105566 |
2025-06-04 | GERN | 1.535 | 0.13 | 0.08 | 106324 |
2025-06-05 | GERN | 1.56 | 0.13 | 0.01 | 106420 |
2025-06-06 | GERN | 1.6 | 0.13 | 0.00 | 106428 |
2025-06-09 | GERN | 1.61 | 0.12 | 0.75 | 107821 |
2025-06-10 | GERN | 1.595 | 0.12 | 0.02 | 107903 |
2025-06-11 | GERN | 1.53 | 0.12 | 0.07 | 108003 |
2025-06-12 | GERN | 1.565 | 0.12 | 0.03 | 107991 |
2025-06-13 | GERN | 1.505 | 0.12 | 0.04 | 107923 |
2025-06-16 | GERN | 1.56 | 0.12 | 0.00 | 107998 |
2025-06-17 | GERN | 1.455 | 0.12 | 0.00 | 107991 |
2025-06-18 | GERN | 1.545 | 0.12 | 0.46 | 108000 |
2025-06-20 | GERN | 1.49 | 0.12 | 0.01 | 108043 |
2025-06-23 | GERN | 1.425 | 0.13 | 1.25 | 85331 |
2025-06-24 | GERN | 1.545 | 0.15 | 0.01 | 87141 |
2025-06-25 | GERN | 1.515 | 0.15 | 0.00 | 87555 |
2025-06-26 | GERN | 1.52 | 0.15 | 0.08 | 87574 |
2025-06-27 | GERN | 1.485 | 0.15 | 0.00 | 87597 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
19 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-06-02 | GERN | 1.44 | 71.5 | 47.5 | -0.12 |
2025-06-03 | GERN | 1.57 | 71.5 | 31.8 | -0.12 |
2025-06-04 | GERN | 1.53 | 71.5 | 44.7 | -0.12 |
2025-06-05 | GERN | 1.56 | 71.5 | 40.8 | -0.12 |
2025-06-06 | GERN | 1.60 | 71.5 | 39.1 | -0.12 |
2025-06-09 | GERN | 1.62 | 71.5 | 40.8 | -0.12 |
2025-06-10 | GERN | 1.60 | 71.5 | 43.4 | -0.12 |
2025-06-11 | GERN | 1.54 | 71.5 | 45.8 | -0.12 |
2025-06-12 | GERN | 1.56 | 71.5 | 40.8 | -0.12 |
2025-06-13 | GERN | 1.50 | 71.5 | 46.0 | -0.12 |
2025-06-16 | GERN | 1.55 | 71.5 | 39.0 | -0.12 |
2025-06-17 | GERN | 1.45 | 71.5 | 48.7 | -0.12 |
2025-06-18 | GERN | 1.55 | 71.5 | 34.9 | -0.12 |
2025-06-20 | GERN | 1.51 | 71.5 | 44.7 | -0.12 |
2025-06-23 | GERN | 1.43 | 71.5 | 46.2 | -0.12 |
2025-06-24 | GERN | 1.54 | 71.5 | 33.1 | -0.12 |
2025-06-25 | GERN | 1.51 | 71.5 | 44.7 | -0.12 |
2025-06-26 | GERN | 1.52 | 71.5 | 41.0 | -0.12 |
2025-06-27 | GERN | 1.48 | 71.5 | 45.4 | -0.12 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
19 items
«
‹
Current Page1 of 1
›
»
18 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-06-02 | GERN | 0.42 | 4.84 | 11.14 |
2025-06-03 | GERN | 0.42 | 4.84 | 11.14 |
2025-06-04 | GERN | 0.42 | 4.84 | 11.14 |
2025-06-05 | GERN | 0.42 | 4.84 | 11.14 |
2025-06-06 | GERN | 0.42 | 4.84 | 11.14 |
2025-06-09 | GERN | 0.42 | 4.82 | 11.14 |
2025-06-10 | GERN | 0.42 | 4.82 | 11.14 |
2025-06-11 | GERN | 0.42 | 4.82 | 10.70 |
2025-06-12 | GERN | 0.42 | 4.82 | 10.70 |
2025-06-13 | GERN | 0.42 | 4.82 | 10.70 |
2025-06-16 | GERN | 0.42 | 4.85 | 10.70 |
2025-06-18 | GERN | 0.42 | 4.85 | 10.70 |
2025-06-20 | GERN | 0.42 | 4.85 | 10.70 |
2025-06-23 | GERN | 0.42 | 5.00 | 10.70 |
2025-06-24 | GERN | 0.42 | 5.00 | 10.70 |
2025-06-25 | GERN | 0.42 | 5.00 | 10.70 |
2025-06-26 | GERN | 0.42 | 5.00 | 10.81 |
2025-06-27 | GERN | 0.42 | 5.00 | 10.81 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
18 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.03
Avg. EPS Est. Current Quarter
-0.03
Avg. EPS Est. Next Quarter
-0.03
Insider Transactions
0.42
Institutional Transactions
5
Beta
0.67
Average Sales Estimate Current Quarter
46
Average Sales Estimate Next Quarter
52
Fair Value
Quality Score
45
Growth Score
57
Sentiment Score
23
Actual DrawDown %
72.3
Max Drawdown 5-Year %
-76.8
Target Price
3.69
P/E
Forward P/E
PEG
P/S
8.16
P/B
3.54
P/Free Cash Flow
EPS
-0.21
Average EPS Est. Cur. Y
-0.12
EPS Next Y. (Est.)
-0.05
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-119.54
Relative Volume
1.36
Return on Equity vs Sector %
-75.7
Return on Equity vs Industry %
-57.9
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
45.4
Sector: Healthcare
Industry: Biotechnology
Employees: 229
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
stock quote shares GERN – Geron Corporation Stock Price stock today
news today GERN – Geron Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch GERN – Geron Corporation yahoo finance google finance
stock history GERN – Geron Corporation invest stock market
stock prices GERN premarket after hours
ticker GERN fair value insiders trading